 | • レポートコード：QYR9ST09091 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、血友病治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、血友病A、血友病Bに、用途別には、病院、製薬会社、その他にセグメント区分し、血友病治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・血友病治療の世界市場概要 ・血友病治療の製造コスト構成分析 ・血友病治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・血友病治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・血友病治療のセグメント分析（種類別） （血友病A、血友病B） ・血友病治療のセグメント分析（用途別） （病院、製薬会社、その他） ・血友病治療の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Bayer、Novo Nordisk、Pfizer、Roche、Aptevo Therapeutics、Catalyst BioSciences、Dimension Therapeutics、Shire、CSL Behring、Alnylam Pharmaceuticals） ・血友病治療の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
Haemophilia is a mostly inherited genetic disorder that impairs the body’s ability to make blood clots, a process needed to stop bleeding.
The global Haemophilia Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Haemophilia Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Haemophilia Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Haemophilia Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Haemophilia Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Bayer
Novo Nordisk
Pfizer
Roche
Aptevo Therapeutics
Catalyst BioSciences
Dimension Therapeutics
Shire
CSL Behring
Alnylam Pharmaceuticals
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Haemophilia A
Haemophilia B
Segment by Application
Hospital
Pharmaceutical Companies
Other
Table of Contents
Executive Summary
1 Industry Overview of Haemophilia Treatment
1.1 Definition of Haemophilia Treatment
1.2 Haemophilia Treatment Segment by Type
1.2.1 Global Haemophilia Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Haemophilia A
1.2.3 Haemophilia B
1.3 Haemophilia Treatment Segment by Applications
1.3.1 Global Haemophilia Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Pharmaceutical Companies
1.3.4 Other
1.4 Global Haemophilia Treatment Overall Market
1.4.1 Global Haemophilia Treatment Revenue (2014-2025)
1.4.2 Global Haemophilia Treatment Production (2014-2025)
1.4.3 North America Haemophilia Treatment Status and Prospect (2014-2025)
1.4.4 Europe Haemophilia Treatment Status and Prospect (2014-2025)
1.4.5 China Haemophilia Treatment Status and Prospect (2014-2025)
1.4.6 Japan Haemophilia Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Haemophilia Treatment Status and Prospect (2014-2025)
1.4.8 India Haemophilia Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Haemophilia Treatment
2.3 Manufacturing Process Analysis of Haemophilia Treatment
2.4 Industry Chain Structure of Haemophilia Treatment
3 Development and Manufacturing Plants Analysis of Haemophilia Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Haemophilia Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Haemophilia Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Haemophilia Treatment Production and Capacity Analysis
4.2 Haemophilia Treatment Revenue Analysis
4.3 Haemophilia Treatment Price Analysis
4.4 Market Concentration Degree
5 Haemophilia Treatment Regional Market Analysis
5.1 Haemophilia Treatment Production by Regions
5.1.1 Global Haemophilia Treatment Production by Regions
5.1.2 Global Haemophilia Treatment Revenue by Regions
5.2 Haemophilia Treatment Consumption by Regions
5.3 North America Haemophilia Treatment Market Analysis
5.3.1 North America Haemophilia Treatment Production
5.3.2 North America Haemophilia Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Haemophilia Treatment Import and Export
5.4 Europe Haemophilia Treatment Market Analysis
5.4.1 Europe Haemophilia Treatment Production
5.4.2 Europe Haemophilia Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Haemophilia Treatment Import and Export
5.5 China Haemophilia Treatment Market Analysis
5.5.1 China Haemophilia Treatment Production
5.5.2 China Haemophilia Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Haemophilia Treatment Import and Export
5.6 Japan Haemophilia Treatment Market Analysis
5.6.1 Japan Haemophilia Treatment Production
5.6.2 Japan Haemophilia Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Haemophilia Treatment Import and Export
5.7 Southeast Asia Haemophilia Treatment Market Analysis
5.7.1 Southeast Asia Haemophilia Treatment Production
5.7.2 Southeast Asia Haemophilia Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Haemophilia Treatment Import and Export
5.8 India Haemophilia Treatment Market Analysis
5.8.1 India Haemophilia Treatment Production
5.8.2 India Haemophilia Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Haemophilia Treatment Import and Export
6 Haemophilia Treatment Segment Market Analysis (by Type)
6.1 Global Haemophilia Treatment Production by Type
6.2 Global Haemophilia Treatment Revenue by Type
6.3 Haemophilia Treatment Price by Type
7 Haemophilia Treatment Segment Market Analysis (by Application)
7.1 Global Haemophilia Treatment Consumption by Application
7.2 Global Haemophilia Treatment Consumption Market Share by Application (2014-2019)
8 Haemophilia Treatment Major Manufacturers Analysis
8.1 Bayer
8.1.1 Bayer Haemophilia Treatment Production Sites and Area Served
8.1.2 Bayer Product Introduction, Application and Specification
8.1.3 Bayer Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novo Nordisk
8.2.1 Novo Nordisk Haemophilia Treatment Production Sites and Area Served
8.2.2 Novo Nordisk Product Introduction, Application and Specification
8.2.3 Novo Nordisk Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Pfizer
8.3.1 Pfizer Haemophilia Treatment Production Sites and Area Served
8.3.2 Pfizer Product Introduction, Application and Specification
8.3.3 Pfizer Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Roche
8.4.1 Roche Haemophilia Treatment Production Sites and Area Served
8.4.2 Roche Product Introduction, Application and Specification
8.4.3 Roche Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Aptevo Therapeutics
8.5.1 Aptevo Therapeutics Haemophilia Treatment Production Sites and Area Served
8.5.2 Aptevo Therapeutics Product Introduction, Application and Specification
8.5.3 Aptevo Therapeutics Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Catalyst BioSciences
8.6.1 Catalyst BioSciences Haemophilia Treatment Production Sites and Area Served
8.6.2 Catalyst BioSciences Product Introduction, Application and Specification
8.6.3 Catalyst BioSciences Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Dimension Therapeutics
8.7.1 Dimension Therapeutics Haemophilia Treatment Production Sites and Area Served
8.7.2 Dimension Therapeutics Product Introduction, Application and Specification
8.7.3 Dimension Therapeutics Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Shire
8.8.1 Shire Haemophilia Treatment Production Sites and Area Served
8.8.2 Shire Product Introduction, Application and Specification
8.8.3 Shire Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 CSL Behring
8.9.1 CSL Behring Haemophilia Treatment Production Sites and Area Served
8.9.2 CSL Behring Product Introduction, Application and Specification
8.9.3 CSL Behring Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Alnylam Pharmaceuticals
8.10.1 Alnylam Pharmaceuticals Haemophilia Treatment Production Sites and Area Served
8.10.2 Alnylam Pharmaceuticals Product Introduction, Application and Specification
8.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Haemophilia Treatment Market
9.1 Global Haemophilia Treatment Market Trend Analysis
9.1.1 Global Haemophilia Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Haemophilia Treatment Regional Market Trend
9.2.1 North America Haemophilia Treatment Forecast 2019-2025
9.2.2 Europe Haemophilia Treatment Forecast 2019-2025
9.2.3 China Haemophilia Treatment Forecast 2019-2025
9.2.4 Japan Haemophilia Treatment Forecast 2019-2025
9.2.5 Southeast Asia Haemophilia Treatment Forecast 2019-2025
9.2.6 India Haemophilia Treatment Forecast 2019-2025
9.3 Haemophilia Treatment Market Trend (Product Type)
9.4 Haemophilia Treatment Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Haemophilia Treatment Distributors List
10.3 Haemophilia Treatment Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Haemophilia Treatment
Table Global Haemophilia Treatment Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Haemophilia Treatment Production Market Share by Types in 2018
Figure Haemophilia A Product Picture
Figure Haemophilia B Product Picture
Table Global Haemophilia Treatment Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Haemophilia Treatment Consumption Market Share by Applications in 2018
Figure Hospital
Figure Pharmaceutical Companies
Figure Other
Figure Global Haemophilia Treatment Revenue (Million USD) (2014-2025)
Figure Global Haemophilia Treatment Production (K Units) (2014-2025)
Figure North America Haemophilia Treatment Market Size (Million USD) (2014-2025)
Figure Europe Haemophilia Treatment Market Size (Million USD) (2014-2025)
Figure China Haemophilia Treatment Market Size (Million USD) (2014-2025)
Figure Japan Haemophilia Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Haemophilia Treatment Market Size (Million USD) (2014-2025)
Figure India Haemophilia Treatment Market Size (Million USD) (2014-2025)
Table Haemophilia Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Haemophilia Treatment in 2018
Figure Manufacturing Process Analysis of Haemophilia Treatment
Figure Industry Chain Structure of Haemophilia Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Haemophilia Treatment Manufacturing Plants Distribution
Table Haemophilia Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Haemophilia Treatment Capacity (K Units) of Major Manufacturers (2014-2019)
Table Haemophilia Treatment Production (K Units) of Major Manufacturers (2014-2019)
Table Haemophilia Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Haemophilia Treatment Production Share by Manufacturers in 2018
Table Haemophilia Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Haemophilia Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Haemophilia Treatment Revenue Share by Manufacturers in 2018
Table Haemophilia Treatment Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Haemophilia Treatment Production by Regions 2014-2019 (K Units)
Table Global Haemophilia Treatment Production Market Share by Regions 2014-2019
Figure Global Haemophilia Treatment Production Market Share by Regions in 2018
Table Global Haemophilia Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Haemophilia Treatment Revenue Market Share by Regions 2014-2019
Figure Global Haemophilia Treatment Revenue Market Share by Regions in 2018
Table Global Haemophilia Treatment Consumption by Regions 2014-2019 (K Units)
Table Global Haemophilia Treatment Consumption Market Share by Regions 2014-2019
Figure North America Haemophilia Treatment Production Growth Rate 2014-2019 (K Units)
Figure North America Haemophilia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Haemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Europe Haemophilia Treatment Production Growth Rate 2014-2019 (K Units)
Figure Europe Haemophilia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Haemophilia Treatment Production, Consumption Import and Export (K Units)
Figure China Haemophilia Treatment Production Growth Rate 2014-2019 (K Units)
Figure China Haemophilia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Haemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Japan Haemophilia Treatment Production Growth Rate 2014-2019 (K Units)
Figure Japan Haemophilia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Haemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Southeast Asia Haemophilia Treatment Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Haemophilia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Haemophilia Treatment Production, Consumption Import and Export (K Units)
Figure India Haemophilia Treatment Production Growth Rate 2014-2019 (K Units)
Figure India Haemophilia Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Haemophilia Treatment Production, Consumption Import and Export (K Units)
Figure Global Consumption Haemophilia Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Haemophilia Treatment Market Share by Application (2014-2019)
Table Bayer Haemophilia Treatment Production Sites and Area Served
Table Bayer Haemophilia Treatment Product Introduction, Application and Specification
Table Bayer Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Haemophilia Treatment Production Growth Rate (2014-2019)
Table Bayer Haemophilia Treatment Production Market Share (2014-2019)
Figure Bayer Haemophilia Treatment Revenue Market Share (2014-2019)
Table Bayer Haemophilia Treatment Main Business and Markets Served
Table Novo Nordisk Haemophilia Treatment Production Sites and Area Served
Table Novo Nordisk Haemophilia Treatment Product Introduction, Application and Specification
Table Novo Nordisk Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Novo Nordisk Haemophilia Treatment Production Growth Rate (2014-2019)
Table Novo Nordisk Haemophilia Treatment Production Market Share (2014-2019)
Figure Novo Nordisk Haemophilia Treatment Revenue Market Share (2014-2019)
Table Novo Nordisk Haemophilia Treatment Main Business and Markets Served
Table Pfizer Haemophilia Treatment Production Sites and Area Served
Table Pfizer Haemophilia Treatment Product Introduction, Application and Specification
Table Pfizer Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Haemophilia Treatment Production Growth Rate (2014-2019)
Table Pfizer Haemophilia Treatment Production Market Share (2014-2019)
Figure Pfizer Haemophilia Treatment Revenue Market Share (2014-2019)
Table Pfizer Haemophilia Treatment Main Business and Markets Served
Table Roche Haemophilia Treatment Production Sites and Area Served
Table Roche Haemophilia Treatment Product Introduction, Application and Specification
Table Roche Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Haemophilia Treatment Production Growth Rate (2014-2019)
Table Roche Haemophilia Treatment Production Market Share (2014-2019)
Figure Roche Haemophilia Treatment Revenue Market Share (2014-2019)
Table Roche Haemophilia Treatment Main Business and Markets Served
Table Aptevo Therapeutics Haemophilia Treatment Production Sites and Area Served
Table Aptevo Therapeutics Haemophilia Treatment Product Introduction, Application and Specification
Table Aptevo Therapeutics Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Aptevo Therapeutics Haemophilia Treatment Production Growth Rate (2014-2019)
Table Aptevo Therapeutics Haemophilia Treatment Production Market Share (2014-2019)
Figure Aptevo Therapeutics Haemophilia Treatment Revenue Market Share (2014-2019)
Table Aptevo Therapeutics Haemophilia Treatment Main Business and Markets Served
Table Catalyst BioSciences Haemophilia Treatment Production Sites and Area Served
Table Catalyst BioSciences Haemophilia Treatment Product Introduction, Application and Specification
Table Catalyst BioSciences Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Catalyst BioSciences Haemophilia Treatment Production Growth Rate (2014-2019)
Table Catalyst BioSciences Haemophilia Treatment Production Market Share (2014-2019)
Figure Catalyst BioSciences Haemophilia Treatment Revenue Market Share (2014-2019)
Table Catalyst BioSciences Haemophilia Treatment Main Business and Markets Served
Table Dimension Therapeutics Haemophilia Treatment Production Sites and Area Served
Table Dimension Therapeutics Haemophilia Treatment Product Introduction, Application and Specification
Table Dimension Therapeutics Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Dimension Therapeutics Haemophilia Treatment Production Growth Rate (2014-2019)
Table Dimension Therapeutics Haemophilia Treatment Production Market Share (2014-2019)
Figure Dimension Therapeutics Haemophilia Treatment Revenue Market Share (2014-2019)
Table Dimension Therapeutics Haemophilia Treatment Main Business and Markets Served
Table Shire Haemophilia Treatment Production Sites and Area Served
Table Shire Haemophilia Treatment Product Introduction, Application and Specification
Table Shire Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Shire Haemophilia Treatment Production Growth Rate (2014-2019)
Table Shire Haemophilia Treatment Production Market Share (2014-2019)
Figure Shire Haemophilia Treatment Revenue Market Share (2014-2019)
Table Shire Haemophilia Treatment Main Business and Markets Served
Table CSL Behring Haemophilia Treatment Production Sites and Area Served
Table CSL Behring Haemophilia Treatment Product Introduction, Application and Specification
Table CSL Behring Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table CSL Behring Haemophilia Treatment Production Growth Rate (2014-2019)
Table CSL Behring Haemophilia Treatment Production Market Share (2014-2019)
Figure CSL Behring Haemophilia Treatment Revenue Market Share (2014-2019)
Table CSL Behring Haemophilia Treatment Main Business and Markets Served
Table Alnylam Pharmaceuticals Haemophilia Treatment Production Sites and Area Served
Table Alnylam Pharmaceuticals Haemophilia Treatment Product Introduction, Application and Specification
Table Alnylam Pharmaceuticals Haemophilia Treatment Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals Haemophilia Treatment Production Growth Rate (2014-2019)
Table Alnylam Pharmaceuticals Haemophilia Treatment Production Market Share (2014-2019)
Figure Alnylam Pharmaceuticals Haemophilia Treatment Revenue Market Share (2014-2019)
Table Alnylam Pharmaceuticals Haemophilia Treatment Main Business and Markets Served
Figure Global Haemophilia Treatment Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Haemophilia Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Haemophilia Treatment Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Haemophilia Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Haemophilia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Haemophilia Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Haemophilia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Haemophilia Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Haemophilia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Haemophilia Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Haemophilia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Haemophilia Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Haemophilia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Haemophilia Treatment Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Haemophilia Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Haemophilia Treatment by Type (2019-2025)
Table Global Consumption (K Units) of Haemophilia Treatment by Application (2019-2025)
Table Haemophilia Treatment Distributors List
Table Haemophilia Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
好中球減少症治療の世界市場：市場規模・現状・予測 Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms.…- 皮膚肥満細胞症の治療の世界市場：市場規模・現状・予測 Cutaneous mastocytosis is a form of mastocytosis that primarily affects the skin. There are three main forms of the condition: maculopapular cutaneous mastocytosis (also called urticaria pigmentosa), solitary cutaneous mastocytoma, and diffuse cutaneous mastocytosis.In 2018, the global Cutaneous Mas…
- 萎縮性胃炎治療の世界市場：市場規模・現状・予測 Atopic gastritis is chronic inflammation of gastric mucosa, and it is a histopathological condition associated with gastric glandular cell and replacement by fibrous tissue, intestinal type epithelium, and pyloric type glands. It mainly associated H. Pylori bacterial infection, and autoimmunity dire…
- アルコール性肝炎治療薬の世界市場：市場規模・現状・予測 Alcoholic hepatitis is hepatitis (inflammation of the liver) due to excessive intake of alcohol. It is usually found in association with fatty liver, an early stage of alcoholic liver disease, and may contribute to the progression of fibrosis, leading to cirrhosis. The increasing consumption of alco…
- 重症筋無力症治療の世界市場：市場規模・現状・予測 Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …